This is a standard proxy filing with no material financial disclosures or significant corporate actions. Monitor for any shareholder activism or voting results from the annual meeting, but no immediate trading implications.
Price Chart
Executive Summary
Evolent Health, Inc. (EVH) has filed a definitive proxy statement (DEFA14A) for its 2026 Annual Meeting, scheduled for June 4, 2026. The filing outlines four proposals for shareholder vote: election of 10 directors, ratification of Deloitte & Touche LLP as independent auditors, approval of executive compensation, and an amendment to the 2015 Omnibus Incentive Compensation Plan. The filing is routine and does not contain any material financial disclosures or significant corporate actions.
Key Facts
- Filing is a definitive proxy statement (DEFA14A) for Evolent Health's 2026 Annual Meeting
- Meeting date is June 4, 2026, with voting deadline of June 3, 2026
- Four proposals to be voted on: 1) Election of 10 directors, 2) Ratification of Deloitte & Touche LLP as independent auditors, 3) Approval of executive compensation, 4) Amendment to 2015 Omnibus Incentive Compensation Plan
- No material financial information, guidance, or significant corporate actions disclosed
- Filing is routine and required by SEC regulations for annual shareholder meetings
Financial Impact
No financial impact - this is a routine proxy filing with no material financial disclosures
Risk Factors
- Low risk - this is a routine filing with no material disclosures
- Potential for shareholder activism if any of the proposals receive significant opposition
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-177275 |
| Document: 0001193125-26-177275-index-headers.html | 0001193125-26-177275 |
| Document: 0001193125-26-177275-index.html | 0001193125-26-177275 |
| Document: 0001193125-26-177275.txt | 0001193125-26-177275 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 6, 2026 8w ago | 8-K | $3.59 $4.26 | ▲ +18.66% | ▲ +18.06% | $3.46 (−3.62%) |
Jul 8, 2026 12w ago | Press Release | $5.63 $3.59 | ▼ −36.23% | ▼ −38.48% | $3.46 (−38.54%) |
Apr 24, 2026 23w ago | DEFA14A | $3.47 $3.83 | ▲ +10.37% | ▲ +5.42% | $3.46 (−0.29%) |
Feb 24, 2026 31w ago | 8-K | $3.14 $2.27 | ▼ −27.71% | ▼ −22.47% | $3.46 (+10.19%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access